Companies
ZOE
ZOE, co-founded by a King's College London genetic epidemiologist, sells a test-kit-plus-subscription that combines stool shotgun metagenomics, a 14-day Abbott Libre Sense CGM and standardised meals into an app of personal food scores, scaling from the UK into the US.
- Country
- United Kingdom
Commercial
GDPR compliant
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $129M total raised to date | getlatka.com |
| Headcount | 416 employees as of 2025 | getlatka.com |
| Revenue | $80.4M ARR in 2023 | getlatka.com · healthrx.com |
| Regulatory approval | not FDA-regulated as a medical device or drug; uses FDA-cleared CGM devices as a wellness tool | healthrx.com |
| Certification | no LegitScript certification as of January 2025 | healthrx.com |
Independent sources: getlatka.com · healthrx.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Personalized nutrition | regenerative-personalized | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.